Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['cartitude-4', 'cartitude', 'janssen']
excited about the cartitude-4 presentation here at #asco2023 on monday. and legend team meeting and preparing with for an exciting moment on monday. #mycompany 
VP of Oncology Global Medical Affairs at Janssen, J&J

Scientist focused on bringing new treatment options for pts with cancer. Tweets/views shared are my own